The sales are routine post-grant liquidity events with no informational content. Monitor VKTX for upcoming clinical trial catalysts (obesity drug pipeline) which are the primary price drivers, not insider trading patterns at this scale.
Price Chart
Executive Summary
VKTX CFO and COO sold a combined $1.32M in open-market sales on July 29, 2026, at ~$33.47/share, following non-cash stock grants on July 28. The sales represent ~0.03% of VKTX's $3.9B market cap — trivial in proportion. Both executives sold on the same day after receiving identical restricted stock grants, consistent with routine tax- or liquidity-driven sales following vesting, not a bearish signal. The historical calibration for this ticker shows prior neutral reports underperformed, but the current event lacks materiality to drive a directional call.
Key Financial Metrics
Key Facts
- CFO Greg Zante sold 21,217 shares for ~$710K on July 29, 2026 at $33.47
- COO Marianna Mancini sold 18,217 shares for ~$610K on July 29, 2026 at $33.47
- Both executives received identical grants of 31,667 shares each on July 28, 2026 (non-cash, $0 value)
- Total open-market sales of $1.32M represent ~0.03% of VKTX's $3.9B market cap
- Sales occurred one day after non-cash stock grants, consistent with tax withholding or diversification
Financial Impact
Total insider sales of $1.32M, representing 0.03% of market cap — immaterial
Risk Factors
- Insider sales could accelerate if stock appreciates further, but current volume is negligible
- No bearish signal from this cluster — the risk is missing the real catalyst (pipeline data) by over-interpreting routine sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-VKTX-1785370031485 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 30, 2026 9w ago | Insider Cluster | $33.11 $33.86 | ▲ +2.27% | ▼ −1.70% | $29.94 (−9.57%) |
Jul 30, 2026 9w ago | Insider Cluster | $33.11 $33.86 | ▲ +2.27% | ▼ −1.70% | $29.94 (−9.57%) |
Apr 1, 2026 26w ago | DEFA14A | $34.80 $31.18 | ▼ −10.40% | ▼ −20.28% | $29.94 (−13.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access